Dana Investment Advisors Inc. lessened its stake in Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 5.5% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 30,271 shares of the company’s stock after selling 1,759 shares during the period. Dana Investment Advisors Inc. owned 0.15% of Tabula Rasa HealthCare worth $1,930,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in TRHC. Bank of New York Mellon Corp increased its holdings in Tabula Rasa HealthCare by 34.2% during the second quarter. Bank of New York Mellon Corp now owns 214,062 shares of the company’s stock valued at $13,664,000 after buying an additional 54,507 shares during the period. Comerica Bank increased its holdings in Tabula Rasa HealthCare by 12.5% during the third quarter. Comerica Bank now owns 16,284 shares of the company’s stock valued at $1,313,000 after buying an additional 1,806 shares during the period. Wells Fargo & Company MN increased its holdings in Tabula Rasa HealthCare by 673.0% during the third quarter. Wells Fargo & Company MN now owns 187,511 shares of the company’s stock valued at $15,224,000 after buying an additional 163,255 shares during the period. WINTON GROUP Ltd purchased a new position in Tabula Rasa HealthCare during the third quarter valued at approximately $535,000. Finally, Virginia Retirement Systems ET AL purchased a new position in Tabula Rasa HealthCare during the third quarter valued at approximately $365,000. Hedge funds and other institutional investors own 80.52% of the company’s stock.
Several research firms have issued reports on TRHC. BidaskClub raised shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a report on Wednesday, November 28th. Piper Jaffray Companies reaffirmed an “overweight” rating and issued a $80.00 price target on shares of Tabula Rasa HealthCare in a report on Thursday, December 6th. Zacks Investment Research raised shares of Tabula Rasa HealthCare from a “sell” rating to a “hold” rating in a report on Thursday, December 6th. Finally, Benchmark began coverage on shares of Tabula Rasa HealthCare in a report on Tuesday, January 8th. They issued a “buy” rating and a $85.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $83.48.
NASDAQ TRHC opened at $58.22 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.79 and a current ratio of 0.84. Tabula Rasa HealthCare Inc has a 12-month low of $32.64 and a 12-month high of $91.16. The firm has a market capitalization of $1.31 billion, a price-to-earnings ratio of 171.24 and a beta of 1.66.
In other news, President Orsula V. Knowlton sold 8,000 shares of the business’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $57.02, for a total transaction of $456,160.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Brian W. Adams sold 3,035 shares of the business’s stock in a transaction on Thursday, January 3rd. The shares were sold at an average price of $57.45, for a total transaction of $174,360.75. The disclosure for this sale can be found here. Insiders sold 54,057 shares of company stock worth $3,219,378 over the last ninety days. Corporate insiders own 14.00% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Tabula Rasa HealthCare Inc (TRHC) Position Cut by Dana Investment Advisors Inc.” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2019/03/17/tabula-rasa-healthcare-inc-trhc-position-cut-by-dana-investment-advisors-inc.html.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.
Featured Story: How is the LIBOR rate calculated?
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.